Expediting the drug approval process: An analysis of the FDA Modernization Act of 1997

被引：0
|
作者：
Parver, DG [1 ]
机构：
[1] American Univ, Washington Coll Law, Washington, DC 20016 USA
来源：
ADMINISTRATIVE LAW REVIEW | 1999年 / 51卷 / 04期
关键词：
D O I：
暂无
中图分类号：
D9 [法律]; DF [法律];
学科分类号：
0301 ;
摘要：
引用
收藏
页码：1249 / 1266
页数：18
相关论文
共 50 条
  • [31] FDA primer .1. The drug and biologic approval process
    Mackler, BF
    Landa, MM
    Gamerman, GE
    BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY, 1996, 23 : 191 - 196
  • [32] Expediting Patients' Access to Medicines by Improving the Predictability of Drug Development and the Regulatory Approval Process
    Liberti, L.
    Breckenridge, A.
    Eichler, H. G.
    Peterson, R.
    McAuslane, N.
    Walker, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (01) : 27 - 31
  • [33] A lupus drug and FDA approval
    Merrill, JT
    Raymond, S
    SCIENCE, 2005, 308 (5721) : 497 - 497
  • [34] Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process
    Masciale, Andrea C.
    DeSantis, Patricia L.
    Siegel, Jay P.
    DRUG INFORMATION JOURNAL, 2012, 46 (01): : 35 - 42
  • [35] Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process
    Andrea C. Masciale
    Patricia L. DeSantis
    Jay P. Siegel
    Drug information journal : DIJ / Drug Information Association, 2012, 46 : 35 - 42
  • [36] FDA Modernization Act 2.0 and reproductive research
    Samantha G. Zambuto
    Adrienne K. Scott
    Michelle L. Oyen
    Nature Reviews Bioengineering, 2024, 2 (12): : 984 - 986
  • [37] FDA gets advice on Modernization Act compliance
    Marwick, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (14): : 1214 - 1215
  • [38] FDA comes under scrutiny - Drug trials, approval process questioned
    不详
    AMERICAN JOURNAL OF NURSING, 2005, 105 (06) : 29 - 30
  • [39] How to access and process FDA drug approval packages for use in research
    Turner, Erick H.
    BMJ-BRITISH MEDICAL JOURNAL, 2013, 347
  • [40] Carvedilol and the food and drug administration (FDA) approval process: The FDA paradigm and reflections on hypothesis testing
    Fisher, LD
    CONTROLLED CLINICAL TRIALS, 1999, 20 (01): : 16 - 39
12345